On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
National Health IT Week at the FCC
This week the Federal Communications Commission’s (FCC’s) CONNECT2HEALTHFCC Task Force, a group formed in March 2014 that is focused on using broadband deployment to accelerate the adoption of advanced healthcare technologies, is joining more than 400 other public and private organizations in recognizing National Health IT Week (NHIT week). NHIT week is a series of events and activities aimed at increasing awareness of the ability of information technology (IT) to advance healthcare services. For example, health IT, or electronic health records, can improve healthcare by increasing patient safety, decreasing medical errors, and facilitating better communication between patients and their healthcare providers. The themes for this year’s NHIT week include patient engagement, advancing interoperability, and clinical quality and safety.
NHIT week began September 15 with the Annual Consumer Health IT Summit hosted by the Office of the National Coordinator for Health IT. FCC Commissioner Mignon Clyburn delivered the keynote address at the Summit and will also present at the First Annual National Health IT Collaborative for the Underserved Conference on Tuesday, September 16. The Conference will focus on strategies for using Health IT to eliminate disparities in healthcare and ensure that all patients have and use the tools available to maintain their health and well-being. Additional NHIT week events include a webinar on new electronic health record certification criteria and a webinar on using health IT to improve the safety of healthcare.
The author wishes to thank Leigh Gusky, an Associate in our Washington, D.C. office, for her assistance in preparing this article.
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017